- Trials with a EudraCT protocol (1,924)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (8)
1,924 result(s) found for: Clinical effectiveness.
Displaying page 1 of 97.
EudraCT Number: 2008-005019-16 | Sponsor Protocol Number: ROCKSAN | Start Date*: 2009-03-19 |
Sponsor Name:AMC- academisch psychiatrisch centrum | ||
Full Title: Randomized Olanzapine Clozapine Key study on Schizophrenia and Addiction in the Netherlands (ROCKSAN) | ||
Medical condition: A multi-centre prospective, randomized, double blind designed study examining the effectiveness and costs of clozapine compared to olanzapine in patients with schizophrenia or related psychotic dis... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007645-12 | Sponsor Protocol Number: 250101 | Start Date*: 2008-07-15 |
Sponsor Name:University of York | ||
Full Title: The Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) Trial | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004884-38 | Sponsor Protocol Number: FER-LOX-2016-01 | Start Date*: 2017-09-13 |
Sponsor Name:Vall d'Hebron University Hospital | ||
Full Title: Prospective naturalistic clinical trail with loxapine in agitated patients with personality disorder | ||
Medical condition: Acute pre/agitated patients with personality disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-000319-30 | Sponsor Protocol Number: SECTOR | Start Date*: 2022-03-09 |
Sponsor Name:Institut Klinické a Experimentální Medicíny | ||
Full Title: Assessment of association between 3rd dose of mRNA vaccine and risk of SARS-CoV-2 infection in kidney transplant recipients, safety and immunogenicity assessment. | ||
Medical condition: SARS-CoV-2 infection in kidney transplant recipients; safety, effectiveness and immunogenicity of 3rd dose of SARS-CoV-2 mRNA vaccine. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001181-41 | Sponsor Protocol Number: CN138-125 | Start Date*: 2005-01-10 |
Sponsor Name:Bristol-Myers Squibb International Corporation | ||
Full Title: A Prospective, Multicenter, Open-Label Study of Aripiprazole in the Management of Patients with Schizophrenia in General Psychiatric Practices | ||
Medical condition: Schizophrenia or schizoaffective disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SK (Completed) CZ (Completed) HU (Completed) LT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000105-38 | Sponsor Protocol Number: 04/11/02 | Start Date*: 2006-08-04 |
Sponsor Name:King's College London (IOP) | ||
Full Title: A definitive multi-centre pragmatic randomised controlled double-blind trial of the clinical and cost effectiveness of mirtazapine and sertraline versus placebo for the treatment of depression in d... | ||
Medical condition: Depression in dementia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-003250-23 | Sponsor Protocol Number: 78162.018.21 | Start Date*: 2025-01-24 | ||||||||||||||||
Sponsor Name:Amsterdam UMC | ||||||||||||||||||
Full Title: Cannabidiol (Epidyolex) for behavioural problems in patients with Tuberous Sclerosis Complex, Sanfilippo and Fragile X Syndrome: an N-of-1 series | ||||||||||||||||||
Medical condition: Tuberous Sclerosis Complex (TSC), Sanfilippo syndrome, Fragile X syndrome (FXS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001995-13 | Sponsor Protocol Number: BREATH-19 | Start Date*: 2020-05-15 | |||||||||||
Sponsor Name:Fundación SEIMC-GESIDA | |||||||||||||
Full Title: A multicentre, open-label clinical trial to evaluate the effectiveness and safety of intravenous tocilizumab for treating patients with COVID-19 pneumonia: the BREATH-19 Study | |||||||||||||
Medical condition: COVID-19 pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001284-44 | Sponsor Protocol Number: MEDLARV-CLIN-01 | Start Date*: 2011-11-14 |
Sponsor Name:MAGGOT 2006 Egészségügyi, Kereskedelmi és Szolgáltató Ltd. | ||
Full Title: A RANDOMIZED, OPEN, SELF-CONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF LARVAL THERAPY IN PATIENTS WITH LEG ULCERS | ||
Medical condition: Venous or mixed venous/arterial ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002110-42 | Sponsor Protocol Number: PHRCIR2015DAPOIGNY | Start Date*: 2017-10-18 |
Sponsor Name:CHU CLERMONT-FERRAND | ||
Full Title: Evaluation of the effectiveness and safety of ethosuximide in the treatment of abdominal pain associated with irritable bowel syndrome | ||
Medical condition: abdominal pain related to irritable bowel syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002942-35 | Sponsor Protocol Number: CTU/2017/285 | Start Date*: 2019-10-31 | ||||||||||||||||
Sponsor Name:University College London Comprehensive Clinical Trials Unit | ||||||||||||||||||
Full Title: A Randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo and standard psychological care for depression in Parkinson’s Disease | ||||||||||||||||||
Medical condition: Depression in Parkinson's disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000078-39 | Sponsor Protocol Number: GEO-2014/01-HR | Start Date*: 2016-05-25 |
Sponsor Name:PLIVA Hrvatska d.o.o. | ||
Full Title: A prospective, multicentre, uncontrolled study of Geonistin vaginal tablets effectiveness with pharmacokinetic evaluation for unspecific and mixed vulvovaginal infections characterized by vaginal d... | ||
Medical condition: Unspecific and mixed vulvovaginal infections characterized by vaginal discharge. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: HR (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001766-25 | Sponsor Protocol Number: CASM981CVE01 | Start Date*: 2017-09-28 |
Sponsor Name:Novartis | ||
Full Title: An open label, 52 week, multicenter study, of long term management to evaluate effectiveness, tolerability and safety of pimecrolimus cream 1% in pediatric patients with mild to moderate atopic der... | ||
Medical condition: mild to moderate atopic dermatitis | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2008-006846-24 | Sponsor Protocol Number: HTA074801 | Start Date*: 2009-02-27 |
Sponsor Name:North West London Hospitals NHS Trust | ||
Full Title: An Evaluation of the Effectiveness of Ibuprofen and Morphine for Acute Pain in Sickle Cell Disease | ||
Medical condition: Sickle Cell Disease | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002293-44 | Sponsor Protocol Number: PRAKYFRA-01 | Start Date*: 2018-07-25 | |||||||||||
Sponsor Name:VIFOR FRANCE | |||||||||||||
Full Title: A Pragmatic randomized study to evaluate the comparative effectiveness of Akynzeo® and Standard of care (including Emend®) for the prevention of nausea and vomiting (CINV) in cancer patients receiv... | |||||||||||||
Medical condition: prevention of nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001435-27 | Sponsor Protocol Number: CHUBX2020/12 | Start Date*: 2020-04-10 |
Sponsor Name:CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX, ETABLISSEMENT PUBLIC | ||
Full Title: Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19) : a multiarm, multi-stage (MAMS) randomized trial to assess the efficacy and safety of several experimental treat... | ||
Medical condition: severe acute respiratory syndrome coronavirus 2(SARS-CoV 2) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004167-19 | Sponsor Protocol Number: 658321 | Start Date*: 2010-01-11 |
Sponsor Name:GGz Nijmegen | ||
Full Title: The effectiveness of antidepressants and psychological intervention in treating conversion disorder, motor type: a randomized placebo controlled clinical trial. | ||
Medical condition: Conversion disorder, motor type. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004860-29 | Sponsor Protocol Number: Panik-Cyclo | Start Date*: 2007-05-11 |
Sponsor Name:Charité- Universitätsmedizin Berlin | ||
Full Title: D-Cycloserine supported exposure in panic disorder | ||
Medical condition: Panic disorder agoraphobia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000792-11 | Sponsor Protocol Number: | Start Date*: 2014-07-09 |
Sponsor Name:University of Warwick | ||
Full Title: Prehospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest | ||
Medical condition: Out of hospital cardiac arrest | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001186-33 | Sponsor Protocol Number: AIV_FLU_2019_01_VIGIRA_JDD | Start Date*: 2019-09-27 |
Sponsor Name:FISABIO | ||
Full Title: Clinical trial, phase IV, randomized, double-blind, controlled, in children aged 12 to 35 months, of the vaccine against seasonal influenza to estimate efficacy against influenza and other respirat... | ||
Medical condition: Flu and acute respiratory infections | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
